Clinical Trials
7 trialsNCT06241352 2025-05-11
Statin Addition to Chemotherapy for Advanced Pancreatic Cancer
Changhai Hospital
Phase 2 Completed
NCT06422156 2024-05-20
Nim-PC-28
Peking University Third Hospital
Phase 2 Unknown
NCT06329947 2024-05-08
A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT05298020 2022-03-28
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 2 Unknown
NCT03662035 2018-09-19
ASPC
Changzhou No.2 People's Hospital
Phase 2 Unknown
NCT02124317 2016-12-22
NAPSPAC
Chinese PLA General Hospital
Phase 2 Unknown
NCT02135822 2014-05-16
NAPGAP
Chinese PLA General Hospital
Phase 2 Unknown